MARIJUANA: HERE’S HOW INVESTORS SHOULD THINK ABOUT THE FDA’S WARNING ON CBD $APHA $CGC $CRON $NBEV $ACB $MJ $CURLF $MMNFF $TLRY $GTBIF $KSHB $GWPH $SMG $STZ $CVSI $CWEB $CWBHF

The U.S. Food and Drug Administration has thrown a big impediment in the way of marijuana investors.

Before discussing the FDA’s move, let’s build some background with the help of a chart.

Please click here for a chart showing segmented money flows in 16 popular marijuana stocks.

Note the following:

• Smart money flows are neutral in Aphria APHA, Canopy Growth CGC, Cronos CRON and New Age Beverages NBEV.

• Smart money flows are mildly negative in Aurora Cannabis ACB.

• Smart money flows are negative in marijuana ETF MJ.

• Smart money flows are negative in Curaleaf CURLF, Liberty Health LHSIF, MedMen MMNFF and Tilray TLRY.

• Smart money flows are mildly positive in Green Thumb Industries GTBIF.

• Among marijuana-related stocks, smart money flows are mildly positive in Corbus Pharmaceuticals CRBP and KushCo Holdings KSHB.

• Among marijuana-related stocks, smart money flows are negative in GW Pharmaceuticals GWPH, Scotts Miracle-Gro SMG  and Constellation Brands STZ.

FDA news

It is important for investors to go directly to the source and read the FDA news release carefully. The FDA warned 15 companies for illegally selling various products containing cannabidiol on safety concerns. Here are the important points:

• Before forming an opinion of the FDA, keep in mind that the FDA’s intention is to protect the public from harm. The FDA is well-intentioned. The key is to expedite the research.

• The FDA’s stance is comprehensive.

• It will be difficult and expensive for the companies to fight the FDA.

• Many hope there will be political pressure on the FDA to moderate its stance.

• It is conceivable that, due to political pressure, the FDA does not follow through with strict implementation. However, if it does, many companies will be in big trouble…Read more at MarketWatch.

A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER